Member Info for EmeraldCarrots

In 2 clinical studies. Most likely Astrazenica. If it's another one it would be even better in fact. Validation Parsortix delivers the CTC's that major pharma Companies WANT to further investigate. If one does then others do, or will want to as well in time. Other Plc will wonder what this Plc that wants to use Parsortix is on to............ Clearly they are on to something or they would not be investing the cash. Maybe to do with the Androgen Receptor detection assay...............?

We will see.

Up 19%.

All IMHO.

This is the break Cellbxhealth has been chasing for years. I know!

TWO clinical studies. Astrazeneca paid us to develop 2 assays for them (and anyone else to use in fact). There is REAL demand to use Parsortix in cancer drug studies. This is not fiction.

"is in advanced discussions with one of the largest private US healthcare providers to use CelLBxHealth's Parsortix® platform in two clinical studies and is also in the final stages of concluding a Master Services Agreement with a top ten global pharmaceutical company for the use of the Parsortix® platform to potentially support drug discovery and development.".

==================================

All IMHO.

"is in advanced discussions with one of the largest private US healthcare providers to use CelLBxHealth's Parsortix® platform in two clinical studies and is also in the final stages of concluding a Master Services Agreement with a top ten global pharmaceutical company for the use of the Parsortix® platform to potentially support drug discovery and development.".

==================================

I think they are making massive mistakes here. People need to put their bias to one side and think what the facts are. The USA has militarily won the war. Iran needs MONEY. It's all very well saying we will get by and do without but in time it will simply ***destroy Iran from within***. They need money and as 90% of their income relies on the Strait of Hormuz they need to get it open asap.

All IMHO.

One wonders if the 2 studies are to do with the previous Androgen Receptor detection assay development with Astras, or the DNA damage response one, or even both?

=================================

"is in advanced discussions with one of the largest private US healthcare providers to use CelLBxHealth's Parsortix® platform in two clinical studies and is also in the final stages of concluding a Master Services Agreement with a top ten global pharmaceutical company for the use of the Parsortix® platform to potentially support drug discovery and development.".

==================================

This has got 2p+ a share written all over it if you ask me.

=================================

"is in advanced discussions with one of the largest private US healthcare providers to use CelLBxHealth's Parsortix® platform in two clinical studies and is also in the final stages of concluding a Master Services Agreement with a top ten global pharmaceutical company for the use of the Parsortix® platform to potentially support drug discovery and development.".

==================================

"is in advanced discussions with one of the largest private US healthcare providers to use CelLBxHealth's Parsortix® platform in two clinical studies and is also in the final stages of concluding a Master Services Agreement with a top ten global pharmaceutical company for the use of the Parsortix® platform to potentially support drug discovery and development.".

==================================

If it's Astrazeneca which is most likely the other top Plc's will take note. We already have some dealings with Roche.

Likely to lead to regular contracts in the future on a simplified basis.

If it's NOT Astra is will be even more interesting.

"is in advanced discussions with one of the largest private US healthcare providers to use CelLBxHealth's Parsortix® platform in two clinical studies and is also in the final stages of concluding a Master Services Agreement with a top ten global pharmaceutical company for the use of the Parsortix® platform to potentially support drug discovery and development.".

==========================

USA investors will love this.

The sp is so low thay might as well buy us.......................? 2p a share?????

Ahem. A deal with one if these then!

Top Ten Pharmaceutical Companies (2026 Context)As of early 2026, the top pharmaceutical companies based on revenue and market influence include organizations such as:-

Johnson & Johnson (J&J)

RocheEli LillyMerck & Co. (MSD)

Pfizer

AbbVie

Novartis

AstraZeneca

Sanofi

Bristol Myers Squibb (BMS)

"The Company is in advanced discussions with one of the largest private US healthcare providers to use CelLBxHealth's Parsortix® platform in two clinical studies and is also in the final stages of concluding a Master Services Agreement with a top ten global pharmaceutical company for the use of the Parsortix® platform to potentially support drug discovery and development. Further updates will be provided to shareholders in due course."

Https://edition.cnn.com/2026/05/10/world/live-news/iran-war-news?t=1778428421929

That is it I believe. Iran seems to under the impression it is in a position to dictate some terms, which seems from where I'm sitting "wishfull thinking". I imagine the USA will either just continue with the blockade or add bombing to it. Meanwhile the 50 plus countries who pledged to keep the strait open have now got ships on the way. Iran's oil storge is either at or near full, meaning they will have to shut nealy all the wells down. When they open them up some will only deliver 60% of the flow rate they did before. I think Iran are commiting economic suicide. I guess the USA will send warships to the strait, Iran will attack, and the USA will bomb the missile launch and associated sites. They will probably disable more oil tankers as repairs will almost certaimly need a dry dock, so out of action for many months. If I were Iran would do whatever deal gets the cash flowing. The way they are playing this seems wreckless, with no thought for the future and is frankly stupid IMHO.

All IMHO.

French and UK ships now on the way to the Strait of Hormuz plus ? knows how many other ships from the 50 plus countries that pledged support to keep the strait open. We are heading for a load of ships it the Persian Gulf specifically to keep the strait open. When Iran fires at the ships those countries will respond by firing back and bombing Iran. The blockade will continue and the people in Iran will have nothing. Will no money Iran will strugggle to replace missiles etc (something the "hard liners" need to take on board) or indeed function as a Country. Another Sudan? Iran has made a new offer apparently. I doubt whether Trump will be interested now the other ships are on their way. It may be too late.

All IMHO.

Missing the obvious - the trading update RNS on 30th April is the reason. Good news expected, it seems.

RNS Regulatory News

RNS Number : 4838C

CelLBxHealth PLC

30 April 2026

"Guildford, UK and Plymouth Meeting, U.S. - 30 April 2026 - CelLBxHealth plc (AIM: CLBX), a CTC intelligence company specialising in innovative circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology, announces that it will provide a trading update for Q1 2026 in mid-May.

=================================

Mid may is this week of course.

Machines are installed available 24hrs a day, 7 days a week. Minimum 2 machines per neonatal ward as the photos show. NICE should recommend the The MT-RNR1 is installed in every neonatal ward in the UK. One wonders if that would mean Countries like Bermuda, the Falklands etc... would be ordering them too? Maybe the staff at Genedrive don't realise the potential workload here. A load more jobs in Manchester of the cards

All IMHO.

That is the question. Numerous potential deals possible. With Astrazeneca, Immatics, Roche, the UK's NHS, Myriad Genetics, etc... etc.... Maybe, finally, we have a proper major deal. The tech deserves it, as do the people with cancer that would benefit in time.

All IMHO.

Any deal with Astrazeneca would do. I wonder if they have another "angle" they want to investigate regarding CTC's. Cellbxhealth would be the ideal Company do do any research into CTC's. Any. CLBX must be the Worlds 1st choice for investigating CTC's.

Al IMHO.

So something is different.

Candidates for the Astrazeneca cancer drug truqap?

AI Overview

Yes, the ANGLE plc Parsortix® PC1 system can be used to identify and monitor candidates for AstraZeneca’s Truqap (capivasertib), particularly by analyzing circulating tumor cells (CTCs) for specific biomarkers.Parsortix is a liquid biopsy system that isolates and harvests intact cancer cells (CTCs) from a simple blood draw, enabling "real-time" assessment of tumor characteristics without needing invasive tissue biopsies.Here is how Parsortix technology relates to finding the best candidates for Truqap:1. Identifying Specific Biomarker Alterations. Truqap is approved for HR-positive, HER2-negative advanced breast cancer patients who have specific gene alterations: PIK3CA, AKT1, or PTEN.CTC Analysis: The Parsortix system captures intact CTCs from blood. These captured cells can then be used for downstream analysis, such as identifying the presence of PTEN loss or PIK3CA/AKT1 mutations.Advantage over ctDNA: Unlike circulating tumor DNA (ctDNA) which only provides genetic mutations, Parsortix harvests intact cells, which allows for a more detailed analysis, including gene expression (RNA) and protein levels (e.g., PTEN protein loss).

Astra RNS 1st May >>>>>>>

https://www.lse.co.uk/rns/AZN/fda-odac-recommends-truqap-in-prostate-cancer-a0vpgaettfsc8cv.html